SMITHKLINE SKB AIMS FOR PCT EARNINGS RAISE PHILADELPHIA March SmithKline Beckman Corp said it is pursuing a three point stragey that will achieve a pct annual increase in operating earnings throughout the remainder of the decade In SmithKline earned mln dlrs or dlrs per share on revenues of billion dlrs The company said in its annual report that its nonpharmaceutical business will play a major role in meeting its earnings growth target and will in fact grow faster than its pharmaceutical business SmithKline whose major product is the antiulcer medication Tagamet said in the report that it intends to improve earnings from existing products expand its product portfolio and optimize its financial resources To bolster its position in the antiulcer market in which Tagamet has met stiff competition SmithKline said its strategy to develop an over the counter version of Tagamet is bolstered by two joint ventures one with Wellcome PLC and one pending venture in Japan SmithKline also said its Allergan Inc eye and skin care products division can be a one billion dlr organization in the next five years that can grow at more than seven to pct annually Nondilutive acquisitions are a real possibility Gavin Herbert president of the eye and skin care product group said in the report In Allergan had worldwide sales of mln dlrs It said its Smith Kline and French Laboratories pharmaceuticals unit with sales of billion dlrs will file for Food and Drug Administration marketing approval for a number of cardiovascular agents including tissue plasminogen activator over the next two years It also said SK and F s U S sales force will be pct larger in with more than sales personnel Smith Kline also said its small clinical laboratory testing unit with sales of mln dlrs performs mln tests a year and sees increases in employee drug testing as well as in testing for the AIDS antibody Smith Kline said that depending on its share price and the cost of money it may buy back more shares In the last three years it has bought back about pct of its shares SmithKline begins the year with a new management team including its new chief operating officer George Ebright Reuter